Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated fromSalvia miltiorrhizafor the treatment of ischaemic heart diseases-Reference-Cited by-同舟云学术

Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated fromSalvia miltiorrhizafor the treatment of ischaemic heart diseases

Published:2008-02 Issue:2 Volume:38 Page:185-222
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Bi H.-C.,Zuo Z.,Chen X.,Xu C.-S.,Wen Y.-Y.,Sun H.-Y.,Zhao L.-Z.,Pan Y.,Deng Y.,Liu P.-Q.,Gu L.-Q.,Huang Z.-Y.,Zhou S.-F.,Huang M.

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/00498250701767675

Reference71 articles.

1. Reaction of tanshinones with biogenic amine metabolites in vitro

2. Study of tanshinone IIA tissue distribution in rat by liquid chromatography-tandem mass spectrometry method

3. Asymmetric diastereoselective syntheses of the aphid insect pigment derivatives quinone A and quinone A′

4. Structure elucidation and total synthesis of new tanshinones isolated from Salvia miltiorrhiza Bunge (Danshen)

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3-Hydroxytanshinone Inhibits the Activity of Hypoxia-Inducible Factor 1-α by Interfering with the Function of α-Enolase in the Glycolytic Pathway;Molecules;2024-05-09

2. Prospective pharmacological potential of cryptotanshinone in cancer therapy;Pharmacological Research - Modern Chinese Medicine;2023-12

3. Pharmacological Actions of Tanshinone IIA with Special Focus on Nrf-2 Signaling Pathway;Revista Brasileira de Farmacognosia;2023-06-28

4. Therapeutic Significance of Tanshinone;Adaptation under Stressful Environments through Biological Adjustments and Interventions;2023

5. Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets;Frontiers in Cardiovascular Medicine;2022-04-22